Boustead Securities
- Apr 6, 2017
- 0 min read

Boustead’s Dan McClory discusses Trump-Xi Summit

Recent Posts

Boustead IPO Client Blue Water Vaccines ("BWV") Announces Closing of Initial Public Offering

Boustead IPO Client HeartCore Enterprises, Inc. Announces Closing of $15.0 Million Nasdaq IPO

Boustead Client HeartCore Enterprises, Inc. ("HTCR") Announces Pricing of $15.0 Million IPO